v3.25.2
Condensed Statements of Convertible Preferred Stock and Stockholders' Equity/ (Deficit) - USD ($)
$ in Thousands
Total
Convertible Preferred Stock
Common Stock
Additional paid-in-capital
Accumulated other comprehensive income/ (loss)
Accumulated deficit
Beginning balance, convertible preferred stock, (in shares) at Dec. 31, 2023   287,447,000        
Beginning balance, convertible preferred stock at Dec. 31, 2023   $ 247,617        
Beginning balance, (in shares) at Dec. 31, 2023     1,247,000      
Beginning balance at Dec. 31, 2023 $ (127,082)     $ 8,987 $ 40 $ (136,109)
Vesting of early exercised stock options, (in shares)     1,000      
Vesting of early exercised stock options, value 2     2    
Exercise of stock options Value 59     59    
Exercise of stock options (in shares)     15,000      
Stock-based compensation 1,328     1,328    
Unrealized gain (loss) on short-term investments (61)       (61)  
Net loss (15,430)         (15,430)
Ending balance, (in shares) at Mar. 31, 2024     1,263,000      
Ending balance at Mar. 31, 2024 (141,184)     10,376 (21) (151,539)
Ending balance, convertible preferred stock at Mar. 31, 2024   $ 247,617        
Ending balance, convertible preferred stock, (in shares) at Mar. 31, 2024   287,447,000        
Beginning balance, convertible preferred stock, (in shares) at Dec. 31, 2023   287,447,000        
Beginning balance, convertible preferred stock at Dec. 31, 2023   $ 247,617        
Beginning balance, (in shares) at Dec. 31, 2023     1,247,000      
Beginning balance at Dec. 31, 2023 (127,082)     8,987 40 (136,109)
Ending balance, (in shares) at Jun. 30, 2024     22,254,000      
Ending balance at Jun. 30, 2024 179,246   $ 2 347,823 (64) (168,515)
Beginning balance, convertible preferred stock, (in shares) at Mar. 31, 2024   287,447,000        
Beginning balance, convertible preferred stock at Mar. 31, 2024   $ 247,617        
Beginning balance, (in shares) at Mar. 31, 2024     1,263,000      
Beginning balance at Mar. 31, 2024 (141,184)     10,376 (21) (151,539)
Issuance of common stock in initial public offering, net of $12,305 in discounts and offering costs, value 87,695   $ 1 87,694    
Issuance of common stock in initial public offering, net of $12,305 in discounts and offering costs, (in shares)     6,250,000      
Conversion of convertible preferred stock into common stock upon initial public offering, value   $ (247,617)        
Conversion of convertible preferred stock into common stock upon initial public offering, (in shares)   (287,447,000)        
Conversion of convertible preferred stock into common stock upon initial public offering, value 247,617   $ 1 247,616    
Conversion of convertible preferred stock into common stock upon initial public offering, (in shares)     14,741,000      
Vesting of early exercised stock options, value 2     2    
Stock-based compensation 2,135     2,135    
Unrealized gain (loss) on short-term investments (43)       (43)  
Net loss (16,976)         (16,976)
Ending balance, (in shares) at Jun. 30, 2024     22,254,000      
Ending balance at Jun. 30, 2024 179,246   $ 2 347,823 (64) (168,515)
Beginning balance, (in shares) at Dec. 31, 2024     22,300,000      
Beginning balance at Dec. 31, 2024 150,642   $ 2 351,991 121 (201,472)
Stock-based compensation 1,797     1,797    
Unrealized gain (loss) on short-term investments (89)       (89)  
Net loss (15,758)         (15,758)
Ending balance, (in shares) at Mar. 31, 2025     22,300,000      
Ending balance at Mar. 31, 2025 136,592   $ 2 353,788 32 (217,230)
Beginning balance, (in shares) at Dec. 31, 2024     22,300,000      
Beginning balance at Dec. 31, 2024 $ 150,642   $ 2 351,991 121 (201,472)
Exercise of stock options (in shares) 0          
Ending balance, (in shares) at Jun. 30, 2025     22,386,000      
Ending balance at Jun. 30, 2025 $ 122,691   $ 2 355,598 (4) (232,905)
Beginning balance, (in shares) at Mar. 31, 2025     22,300,000      
Beginning balance at Mar. 31, 2025 136,592   $ 2 353,788 32 (217,230)
Stock-based compensation 1,693     1,693    
Issuance of common stock under the Employee Stock Purchase Plan 117     117    
Issuance of common stock under the Employee Stock Purchase Plan (in shares)     86,000      
Unrealized gain (loss) on short-term investments (36)       (36)  
Net loss (15,675)         (15,675)
Ending balance, (in shares) at Jun. 30, 2025     22,386,000      
Ending balance at Jun. 30, 2025 $ 122,691   $ 2 $ 355,598 $ (4) $ (232,905)